Q4 FY2026 EarningsFY2026 revenue reached $7.68M, up 107% YoY, driven by expanded commercialization of the LungFit PH system in the U.S. and initial international sales. Gross profit turned positive at $0.25M compared to a $1.66M loss in FY2025. Net loss narrowed to $34.33M from $48.48M, while operating expenses decreased 32% YoY to $29.30M due to workforce reductions and lower R&D spend. Cash and equivalents stood at $11.64M, with management expressing substantial doubt about the company's ability to continue as a going concern without additional funding.
Preview: Beyond Air(XAIR) predict that the Revenue is 1.907 M (+65.54%), Miss estimate;the EBIT is -7.17 M (+0.06%), Miss estimate;the EPS is -15.4 (+57.22%), Miss estimate.